- Aurora Cannabis (ACB, Financial) introduces its first inhalable resin cartridges in the UK.
- The launch includes two proprietary strains: Sourdough (indica) and Electric Honeydew (sativa).
- The cartridges are manufactured in TGA-GMP certified facilities, ensuring high quality and safety.
Aurora Cannabis Inc. (NASDAQ: ACB), a leading medical cannabis company, has announced the launch of its inaugural inhalable medical cannabis concentrates in the United Kingdom. The company has introduced two 1.2g resin cartridges, Sourdough (indica) and Electric Honeydew (sativa), expanding its global medical cannabis portfolio.
The new inhalable cartridges are designed to provide exceptional flavor profiles, high potency for consistent dosing, and a user-friendly design for convenient and discreet consumption. Manufactured in TGA-GMP certified facilities without additives, these products ensure premium quality and safety standards.
This launch in the UK follows successful implementations in Canada and Australia, demonstrating Aurora's commitment to enhancing patient access to high-quality medical cannabis worldwide. The products are now available nationwide through cannabis retailers. Patients are advised to consult their doctors or clinics for more information.
By introducing these strain-specific cartridges, Aurora is leveraging its proprietary cultivars, marking a significant step in diversifying its product portfolio and expanding its market footprint within the European medical cannabis sector.
